Journal articleHepatogastroenterology2015
Practical prognostic index for survival in patients with unresectable pancreatic cancer treated with gemcitabine or S-1.
- Journal
- Hepatogastroenterology
- Published
- 1 March 2015
- Citations
- 5
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background/aims We performed this retrospective cohort study to identify prognostic factors for unresectable pancreatic cancer treated with current standard therapy using gemcitabine (GEM) or S-1 and to stratify patients prior to treatment using a prognostic index (PI). Methodology We analyzed 182 patients with unresectable pancreatic cancer, who had received GEM or S-1 as first-line chemotherapy. … Excerpt only: this text is the publisher’s. Read it in full at the source.